$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000104733517000042 Filed on February 15, 2017

Income Statement

Concept	2016 Q4	2016	2015 Q4
Revenue	$238.0M	$923.6M	$233.9M
YoY Change	1.74%	1.87%	3.34%
Cost Of Revenue	$142.5M	$548.0M	$140.0M
YoY Change	1.79%	2.87%	2.94%
Gross Profit	$92.40M	$375.6M	$94.00M
YoY Change	-1.7%	0.45%	3.98%
Gross Profit Margin	38.82%	40.66%	40.18%
Selling, General & Admin	$10.30M	$41.29M	$10.00M
YoY Change	3.0%	3.32%	0.0%
% of Gross Profit	11.15%	10.99%	10.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.20M	$39.02M	$9.700M
YoY Change	5.15%	5.14%	4.3%
% of Gross Profit	11.04%	10.39%	10.32%
Operating Expenses	$73.80M	$311.1M	$72.90M
YoY Change	1.23%	2.28%	4.74%
Operating Profit	$17.69M	$60.54M	$20.22M
YoY Change	-12.54%	-9.81%	0.09%
Interest Expense	$3.900M	$3.941M	$4.400M
YoY Change	-11.36%	51.11%	15.79%
% of Operating Profit	22.05%	6.51%	21.76%
Other Income/Expense, Net	$4.876M	$19.67M	$5.246M
YoY Change	-7.05%		19.44%
Pretax Income	$22.60M	$80.21M	$25.50M
YoY Change	-11.37%	-5.94%	3.66%
Income Tax	$8.700M	$29.67M	$10.50M
% Of Pretax Income	38.5%	36.99%	41.18%
Net Earnings	$13.86M	$50.54M	$14.98M
YoY Change	-7.43%	-4.9%	1.19%
Net Earnings / Revenue	5.82%	5.47%	6.4%
Basic Earnings Per Share	$0.92	$3.34	$1.03
Diluted Earnings Per Share	$0.91	$3.32	$0.99
COMMON SHARES
Basic Shares Outstanding		15.13M
Diluted Shares Outstanding		15.21M

Balance Sheet

Concept	2016 Q4	2016	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$164.3M	$164.3M	$154.4M
YoY Change	6.41%	6.46%	-23.68%
Cash & Equivalents	$26.34M	$26.34M	$38.21M
Short-Term Investments	$138.0M	$138.0M	$116.2M
Other Short-Term Assets	$28.50M	$28.55M	$29.30M
YoY Change	-2.73%	-2.37%	0.69%
Inventory	$7.508M	$7.508M	$7.568M
Prepaid Expenses
Receivables	$82.53M	$82.53M	$84.10M
Other Receivables	$8.000M	$7.924M	$3.700M
Total Short-Term Assets	$290.9M	$290.9M	$278.9M
YoY Change	4.27%	4.27%	-13.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$559.6M	$559.6M	$536.0M
YoY Change	4.4%	4.4%	4.14%
Goodwill	$17.60M		$17.60M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments	$37.20M	$37.24M	$37.70M
YoY Change	-1.33%	-1.17%	1.62%
Other Assets	$237.0M	$168.3M	$230.3M
YoY Change	2.88%	3.66%	-2.75%
Total Long-Term Assets	$796.6M	$796.6M	$766.4M
YoY Change	3.94%	3.94%	1.97%
TOTAL ASSETS
Total Short-Term Assets	$290.9M	$290.9M	$278.9M
Total Long-Term Assets	$796.6M	$796.6M	$766.4M
Total Assets	$1.087B	$1.087B	$1.045B
YoY Change	4.03%	4.03%	-2.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.60M	$18.59M	$20.10M
YoY Change	-7.46%	-7.63%	26.42%
Accrued Expenses	$91.80M	$91.81M	$92.40M
YoY Change	-0.65%	-0.65%	6.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$3.481M	$3.300M
YoY Change		6.16%	6.45%
Total Short-Term Liabilities	$150.9M	$150.9M	$150.7M
YoY Change	0.18%	0.18%	-17.92%
LONG-TERM LIABILITIES
Long-Term Debt	$120.0M	$146.7M	$120.0M
YoY Change	0.0%	-2.32%	1100.0%
Other Long-Term Liabilities	$16.30M	$98.09M	$16.29M
YoY Change	0.05%	-6.0%	1.77%
Total Long-Term Liabilities	$136.3M	$244.8M	$136.3M
YoY Change	0.01%	-3.83%	423.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.9M	$150.9M	$150.7M
Total Long-Term Liabilities	$136.3M	$244.8M	$136.3M
Total Liabilities	$417.8M	$417.8M	$287.0M
YoY Change	45.61%	0.85%	36.92%
SHAREHOLDERS EQUITY
Retained Earnings	$391.9M		$368.0M
YoY Change	6.5%		7.0%
Common Stock	$152.0K		$150.0K
YoY Change	1.33%		7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$669.6M	$669.6M	$631.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.087B	$1.087B	$1.045B
YoY Change	4.03%	4.03%	-2.68%

Cashflow Statement

Concept	2016 Q4	2016	2015 Q4
OPERATING ACTIVITIES
Net Income	$13.86M	$50.54M	$14.98M
YoY Change	-7.43%	-4.9%	1.19%
Depreciation, Depletion And Amortization	$10.20M	$39.02M	$9.700M
YoY Change	5.15%	5.14%	4.3%
Cash From Operating Activities	$26.10M	$90.88M	$20.10M
YoY Change	29.85%	9.03%	12.92%
INVESTING ACTIVITIES
Capital Expenditures	-$12.10M	$62.60M	-$19.40M
YoY Change	-37.63%	7.16%	16.87%
Acquisitions
YoY Change
Other Investing Activities	-$12.30M	-$18.88M	-$5.900M
YoY Change	108.47%	31.37%	490.0%
Cash From Investing Activities	-$24.40M	-$81.48M	-$25.40M
YoY Change	-3.94%	11.94%	44.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$2.577M
YoY Change		-75.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.500M	-27.13M	-26.80M
YoY Change	-75.75%	-34.9%	267.12%
NET CHANGE
Cash From Operating Activities	26.10M	90.88M	20.10M
Cash From Investing Activities	-24.40M	-81.48M	-25.40M
Cash From Financing Activities	-6.500M	-27.13M	-26.80M
Net Change In Cash	-4.800M	-17.73M	-32.10M
YoY Change	-85.05%	-43.01%	352.11%
FREE CASH FLOW
Cash From Operating Activities	$26.10M	$90.88M	$20.10M
Capital Expenditures	-$12.10M	$62.60M	-$19.40M
Free Cash Flow	$38.20M	$28.28M	$39.50M
YoY Change	-3.29%	13.4%	14.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016Q4	nhc	Deferred Tax Liabilities Book Basis In Excess Of Tax Basis Of Securities DeferredTaxLiabilitiesBookBasisInExcessOfTaxBasisOfSecurities	2416000
CY2015Q4	nhc	Deferred Tax Liabilities Book Basis In Excess Of Tax Basis Of Securities DeferredTaxLiabilitiesBookBasisInExcessOfTaxBasisOfSecurities	2344000
CY2016	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
CY2015Q4	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49314000
CY2014Q4	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80418000
CY2013Q4	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95634000
CY2016Q4	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31589000
CY2016	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17725000
CY2015	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-31104000
CY2014	nhc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-15216000
CY2016Q4	nhc	Cost To Complete Construction In Progress CostToCompleteConstructionInProgress	7292000
CY2016Q4	nhc	Deferred Tax Liabilities Long Term Investments DeferredTaxLiabilitiesLongTermInvestments	3404000
CY2015Q4	nhc	Deferred Tax Liabilities Long Term Investments DeferredTaxLiabilitiesLongTermInvestments	2962000
CY2016Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	41264000
CY2015Q4	nhc	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	33079000
CY2016	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2007Q3	nhc	Dividend Distribution Rights DividendDistributionRights	1
CY2016	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	7324000
CY2015	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	6809000
CY2014	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	5957000
CY2016	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	1368000
CY2015	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	2141000
CY2014	nhc	Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount	1542000
CY2016	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	42928000
CY2015	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40875000
CY2014	nhc	Equity Method Investment Summarized Financial Information Expenses EquityMethodInvestmentSummarizedFinancialInformationExpenses	40908000
CY2016Q4	nhc	Homecare Services Anticipated Payment Deferred Revenue Percentage HomecareServicesAnticipatedPaymentDeferredRevenuePercentage	0.6
CY2016	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-204000
CY2015	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	-487000
CY2014	nhc	Increase Decrease In Continuing Care Retirement Communities Obligation For Future Services Amount IncreaseDecreaseInContinuingCareRetirementCommunitiesObligationForFutureServicesAmount	238000
CY2016	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	365000
CY2015	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-6277000
CY2014	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	1312000
CY2014Q1	nhc	Initial Lease Term InitialLeaseTerm	P10Y
CY2014Q1	nhc	Number Of Additional Lease Options NumberOfAdditionalLeaseOptions	2
CY2010Q4	nhc	Number Of Additional Lease Options NumberOfAdditionalLeaseOptions	5
CY2014Q1	nhc	Number Of Capitalized Lease Agreements NumberOfCapitalizedLeaseAgreements	3
CY2014Q1	nhc	Number Of Facilities Under Capitalized Lease NumberOfFacilitiesUnderCapitalizedLease	3
CY2016Q4	nhc	Number Of Nursing Facilities Under Medicaid Cost Report Audits NumberOfNursingFacilitiesUnderMedicaidCostReportAudits	11
CY2010Q4	nhc	Number Of Patient Beds In Facility NumberOfPatientBedsInFacility	120
CY2016Q4	nhc	Number Of Variable Interest Entities NumberOfVariableInterestEntities	1
CY2016	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	-1096000
CY2015	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	1942000
CY2014	nhc	Proceeds Payments Tax Benefit Expense From Stockbased Compensation ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation	201000
CY2014Q1	nhc	Term Of Additional Lease Option TermOfAdditionalLeaseOption	P5Y
CY2016Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17019000
CY2015Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	16654000
CY2016Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	3236000
CY2015Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	3440000
CY2016Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	18593000
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	20128000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82531000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84095000
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	65912000
CY2015Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	65338000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	373516000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	339241000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66068000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	53364000
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	211457000
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209469000
CY2016	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-1096000
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	1942000
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	201000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2021000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1982000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	509000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1982000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2021000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5743000
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5583000
CY2016Q4	us-gaap	Assets Assets	1087447000
CY2015Q4	us-gaap	Assets Assets	1045329000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	290857000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	278942000
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	185968000
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	171174000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	79502000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	74671000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	749000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1694000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	717000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	86921000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3157000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2237000
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	216144000
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	201350000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	91211000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	71442000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	89269000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	70223000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	79827000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	74747000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1699000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	14181000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	23291000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	14216000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	23273000
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	183704000
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	321717000
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	286034000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	108730000
CY2015Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	169866000
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	552404000
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	507627000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3481000
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3279000
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	26748000
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	30228000
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.75
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.54
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	37267000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	11267000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	7038000
CY2014Q1	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	5200000
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	30229000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26335000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38208000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69767000
CY2014	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.34
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15162938
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15000616
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15162938
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000616
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	150000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	63242000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41899000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71792000
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Concentration of Credit Risks</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our credit risks primarily relate to cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, marketable securities, restricted marketable securities and notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. Restricted cash and cash equivalents is primarily invested in commercial paper and certificates of deposit with financial institutions and other interest bearing accounts. Accounts receivable consist primarily of amounts due from patients (funded through Medicare, Medicaid, other contractual programs and through private payors) and from other health care companies for management, accounting and other services. We perform continual credit evaluations of our clients and maintain allowances for doubtful accounts on these accounts receivable. Marketable securities and restricted marketable securities are held primarily in accounts with brokerage institutions. Notes receivable relate primarily to secured loans with health care facilities (recorded as notes receivable in the consolidated balance sheets) as discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.</div> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At any point in time we have funds in our operating accounts and restricted cash accounts that are with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party financial institutions. These balances in the U.S. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits. While we monitor the cash balances in our operating accounts, these cash and restricted cash balances could be impacted if the underlying financial institutions fail or could be subject to other adverse conditions in the financial markets. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our financial instruments, principally our notes receivable, are subject to the possibility of loss of the carrying values as a result of the failure of other parties to perform according to their contractual obligations. We obtain various collateral and other protective rights, and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide reserves for potential losses on our financial instruments based on management's periodic review of the portfolio on an instrument by instrument basis. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> for additional information on the notes receivable.</div></div></div></div></div>
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	53705000
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	54027000
CY2016Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	3236000
CY2015Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	3440000
CY2015	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	616757
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	866096000
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	839496000
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	803672000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	24012000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	29322000
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	30235000
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24673000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	32890000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33330000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	661000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3568000
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3095000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	4208000
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-532000
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1172000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4996000
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-759000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	51700000
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	42465000
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3362000
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3315000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	788000
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1506000
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-227000
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-334000
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3942000
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4258000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29628000
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33369000
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1262000
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1342000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	387000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3511000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	8642000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	9142000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	8907000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	8420000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2077000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2055000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2277000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2648000
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	22072000
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9096000
CY2016Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	22072000
CY2015Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	9096000
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1481000
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	945000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3135000
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3135000
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5244000
CY2015Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8451000
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39023000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37114000
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34384000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39023000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37114000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34384000
CY2014	us-gaap	Dividends Common Stock DividendsCommonStock	18974000
CY2015	us-gaap	Dividends Common Stock DividendsCommonStock	22252000
CY2016	us-gaap	Dividends Common Stock DividendsCommonStock	26617000
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6818000
CY2015Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	5996000
CY2015Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2168000
CY2015Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2167000
CY2015Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2152000
CY2015Q4	us-gaap	Dividends Preferred Stock DividendsPreferredStock	332000
CY2016	us-gaap	Dividends Preferred Stock DividendsPreferredStock
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6819000
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8670000
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.34
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.34
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.24
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.32
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.20
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.14
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5680000
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5263000
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	697000
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8059000
CY2015	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6505000
CY2014	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	10288000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	21973000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	23213000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	20922000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	24787000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	26334000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	25157000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	8082000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	7970000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	7305000
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	9177000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	9589000
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	10533000
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	10896000
CY2015Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11091000
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	11540000
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	52105000
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	50464000
CY2014	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	51441000
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	158558000
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	150357000
CY2016	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	816000
CY2015	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	566000
CY2014	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	379000
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29300000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34500000
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34900000
CY2016Q4	us-gaap	Goodwill Goodwill	17600000
CY2015Q4	us-gaap	Goodwill Goodwill	17600000
CY2016	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	45914000
CY2015	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	41776000
CY2014	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	42396000
CY2016	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	880724000
CY2015	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	864846000
CY2014	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	829287000
CY2016Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	229588000
CY2016Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	227768000
CY2016Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	231281000
CY2016Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	238001000
CY2015Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	222407000
CY2015Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	224902000
CY2015Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	225386000
CY2015Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	233927000
CY2016	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	926638000
CY2015	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	906622000
CY2014	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	871683000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	80207000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85274000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	85193000
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6636000
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5845000
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6675000
CY2016	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	205000
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	740000
CY2014	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	319000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29669000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32131000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31824000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	28072000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29846000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	29818000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	156000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	351000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	363000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	27000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	6000
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	27000
CY2016	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	283000
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-372000
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	439000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1783000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1767000
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2207000
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	716000
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	2674000
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	512000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	27668000
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29183000
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36642000
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4665000
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3203000
CY2016	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1535000
CY2015	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4251000
CY2014	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2827000
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4403000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11835000
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5215000
CY2016	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	574000
CY2015	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	5479000
CY2014	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-3603000
CY2016	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	59000
CY2015	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-354000
CY2014	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-501000
CY2016	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-4791000
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	648000
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10000000
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	120000000
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1434000
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	47000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-44000
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	39000
CY2016	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	402000
CY2015	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	406000
CY2014	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-448000
CY2016	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-3526000
CY2015	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-7455000
CY2014	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5652000
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8000
CY2016	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	1597000
CY2015	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	2285000
CY2014	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	2006000
CY2016	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1462000
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1524000
CY2014	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4727000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-60000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	441000
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19000
CY2016	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	4500000
CY2015	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	4500000
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	283000
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1486000
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	477000
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-89000
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2587000
CY2016	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	48303
CY2015	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	456323
CY2014	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	328669
CY2016	us-gaap	Interest Expense InterestExpense	3941000
CY2015	us-gaap	Interest Expense InterestExpense	2608000
CY2014	us-gaap	Interest Expense InterestExpense	2165000
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5705000
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5494000
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	4550000
CY2016	us-gaap	Interest Paid InterestPaid	4528000
CY2015	us-gaap	Interest Paid InterestPaid	2965000
CY2014	us-gaap	Interest Paid InterestPaid	2242000
CY2016Q4	us-gaap	Inventory Net InventoryNet	7508000
CY2015Q4	us-gaap	Inventory Net InventoryNet	7568000
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37242000
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	37683000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	548007000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	532735000
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	510249000
CY2016Q4	us-gaap	Land Land	59812000
CY2015Q4	us-gaap	Land Land	59831000
CY2016Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	4500000
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	41292000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39967000
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	39731000
CY2016Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	108661000
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	103445000
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P5Y
CY2016	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2010Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P10Y
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1087447000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1045329000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	150928000
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	150656000
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120000000
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	120000000
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	110000000
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	44699000
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	116168000
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	120000000
CY2016Q4	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	43
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	138013000
CY2016Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	22773000
CY2015Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	18276000
CY2016Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	160931000
CY2015Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	151590000
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	768000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-27131000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-41675000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-30124000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-81476000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-72784000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-67031000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	90882000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	83355000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	81939000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	13699000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	11866000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	11110000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	13863000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	13242000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	12358000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	12567000
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	14976000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	50538000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	53143000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	53369000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13699000
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11866000
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11110000
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13863000
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11074000
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10191000
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10415000
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14644000
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	50538000
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	46324000
CY2016Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17624000
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	14641000
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	39032000
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4773000
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4925000
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5091000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	10590000
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4876000
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4222000
CY2016Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	13820000
CY2015Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	12704000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	17687000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17436000
CY2016Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	17079000
CY2015Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	13164000
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4130000
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4550000
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5246000
CY2010Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4500000
CY2016Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3259000
CY2015Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	460000
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15706000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13761000
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	20223000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	60542000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	67126000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	68011000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	347750000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	176750000
CY2016Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	9924000
CY2015Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	9865000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	236966000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	230341000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12704000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11244000
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	18423000
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	816000
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	566000
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	379000
CY2016	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	8185000
CY2015	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-7062000
CY2014	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	11614000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	21705000
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-17740000
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	30416000
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	233833000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	227072000
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	217143000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13207000
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12192000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16302000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16294000
CY2016	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19665000
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	45.97
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18148000
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	17182000
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.06
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.16
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	53.10
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	45914000
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	41776000
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	42396000
CY2016	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2015	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8195000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6995000
CY2016	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2015	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	130538000
CY2014	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	601000
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	25795000
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21089000
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	18704000
CY2016	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock
CY2015	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8986000
CY2014	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8670000
CY2016	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1282000
CY2015	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	674000
CY2014	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1975000
CY2016	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5251000
CY2015	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5676000
CY2014	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	767000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62601000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58416000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53298000
CY2016	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	48620000
CY2015	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	60540000
CY2014	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	62165000
CY2016	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	768000
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	6819000
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8670000
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.47
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	62.54
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2648000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2171000
CY2016	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1636000
CY2015	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4948000
CY2014	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3156000
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10772000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10634000
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7429000
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	110000000
CY2014	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	34642000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	47574000
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	48786000
CY2016	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	34642000
CY2015	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	47574000
CY2014	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	48786000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	933140000
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	875287000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	559624000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536046000
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5967000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6583000
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6228000
CY2016	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	816000
CY2015	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	566000
CY2014	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	379000
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3278000
CY2015	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	3089000
CY2014	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	2436000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5254000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11106000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10651000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3125000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8793000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2129000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2313000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	391934000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	368013000
CY2016	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Deferred Revenue </div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National (as discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> and entrance fees that have been and are currently being received upon reservation and occupancy in the independent living centers we operate. The non–refundable portion <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10%)</div> of the entrance fee is included in deferred revenue and is being recognized over the remaining life expectancies of the residents.</div></div></div></div></div>
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177959
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.44
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.92
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.15
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.48
CY2016Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	91162000
CY2015Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	98508000
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	25898000
CY2015Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27069000
CY2016Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65264000
CY2015Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	71439000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	509000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1982000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2021000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0309
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0273
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0268
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.158
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.165
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.173
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0071
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0052
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	177959
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	55.48
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7431000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5447000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	855000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	656
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	46.69
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	46.69
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	57716
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56210
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56291
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3615000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1074552
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	954678
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	621390
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	177959
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y73D
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3615000
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	55.48
CY2016	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y255D
CY2016Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	2345000
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	157590
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	389498
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	499066
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7429000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10634000
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10772000
CY2015	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	130538000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	688112000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	734148000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	630996000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	669611000
CY2014	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6995000
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8195000
CY2016Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	21296000
CY2015Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	21345000
CY2016	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2164000
CY2015	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2551000
CY2014	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-2059000
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1368000
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2141000
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1542000
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div>
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15206997
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14491433
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14222133
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15134518
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13889134
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13816095

Files In Submission

Name	View Source	Status
0001047335-17-000042-index-headers.html	Edgar Link	pending
0001047335-17-000042-index.html	Edgar Link	pending
0001047335-17-000042.txt	Edgar Link	pending
0001047335-17-000042-xbrl.zip	Edgar Link	pending
exhibit21subsidiariesofthere.htm	Edgar Link	pending
exhibit23.htm	Edgar Link	pending
exhibit311flatt.htm	Edgar Link	pending
exhibit312kidd.htm	Edgar Link	pending
exhibit32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20161231.xml	Edgar Link	completed
nhc-20161231.xsd	Edgar Link	pending
nhc-20161231_cal.xml	Edgar Link	unprocessable
nhc-20161231_def.xml	Edgar Link	unprocessable
nhc-20161231_lab.xml	Edgar Link	unprocessable
nhc-20161231_pre.xml	Edgar Link	unprocessable
nhc2016form10k.htm	Edgar Link	pending
nhc2016form10k001.jpg	Edgar Link	pending
nhc2016form10k003.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2016 Q4 Form 10-K Financial Statement

#000104733517000042 Filed on February 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2016 Q4 Form 10-K Financial Statement

#000104733517000042 Filed on February 15, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc